Supplementary Table S1 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
<p>HRR gene mutations found in WGS/WES or clinical BRCA1/2 mutational testing.</p>
Wedi'i Gadw mewn:
| Prif Awdur: | |
|---|---|
| Awduron Eraill: | , , , , , , , , , , , , , , , , , , , , |
| Cyhoeddwyd: |
2025
|
| Pynciau: | |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
| _version_ | 1849927631937470464 |
|---|---|
| author | Sanna Pikkusaari (15055802) |
| author2 | Manuela Tumiati (15011915) Anni Virtanen (15055805) Jaana Oikkonen (14948281) Yilin Li (15055808) Fernando Perez-Villatoro (15055811) Taru Muranen (15055814) Matilda Salko (15055817) Kaisa Huhtinen (15055820) Anna Kanerva (15055823) Heidi Koskela (15055826) Johanna Tapper (15055829) Riitta Koivisto-Korander (15055832) Titta Joutsiniemi (15055835) Ulla-Maija Haltia (15055838) Heini Lassus (15055841) Sampsa Hautaniemi (14948308) Anniina Färkkilä (14948278) Johanna Hynninen (14932815) Sakari Hietanen (14932818) Olli Carpén (14932812) Liisa Kauppi (15055844) |
| author2_role | author author author author author author author author author author author author author author author author author author author author author |
| author_facet | Sanna Pikkusaari (15055802) Manuela Tumiati (15011915) Anni Virtanen (15055805) Jaana Oikkonen (14948281) Yilin Li (15055808) Fernando Perez-Villatoro (15055811) Taru Muranen (15055814) Matilda Salko (15055817) Kaisa Huhtinen (15055820) Anna Kanerva (15055823) Heidi Koskela (15055826) Johanna Tapper (15055829) Riitta Koivisto-Korander (15055832) Titta Joutsiniemi (15055835) Ulla-Maija Haltia (15055838) Heini Lassus (15055841) Sampsa Hautaniemi (14948308) Anniina Färkkilä (14948278) Johanna Hynninen (14932815) Sakari Hietanen (14932818) Olli Carpén (14932812) Liisa Kauppi (15055844) |
| author_role | author |
| dc.creator.none.fl_str_mv | Sanna Pikkusaari (15055802) Manuela Tumiati (15011915) Anni Virtanen (15055805) Jaana Oikkonen (14948281) Yilin Li (15055808) Fernando Perez-Villatoro (15055811) Taru Muranen (15055814) Matilda Salko (15055817) Kaisa Huhtinen (15055820) Anna Kanerva (15055823) Heidi Koskela (15055826) Johanna Tapper (15055829) Riitta Koivisto-Korander (15055832) Titta Joutsiniemi (15055835) Ulla-Maija Haltia (15055838) Heini Lassus (15055841) Sampsa Hautaniemi (14948308) Anniina Färkkilä (14948278) Johanna Hynninen (14932815) Sakari Hietanen (14932818) Olli Carpén (14932812) Liisa Kauppi (15055844) |
| dc.date.none.fl_str_mv | 2025-11-25T13:31:01Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30709570 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Supplementary_Table_S1_from_Functional_Homologous_Recombination_Assay_on_FFPE_Specimens_of_Advanced_High-Grade_Serous_Ovarian_Cancer_Predicts_Clinical_Outcomes/30709570 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Molecular and Cellular Biology Cancer Detection and Diagnosis Therapeutic Research and Development Clinical Research and Trials Biomarkers Prognostic biomarkers Chemotherapy DNA Damage and Repair Drug Resistance Clinical drug resistance Gynecological Cancers Ovarian cancer Precision Medicine |
| dc.title.none.fl_str_mv | Supplementary Table S1 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>HRR gene mutations found in WGS/WES or clinical BRCA1/2 mutational testing.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_7ee9a4abe519f84be3ed229d0f6b8629 |
| identifier_str_mv | 10.1158/1078-0432.30709570 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30709570 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Table S1 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical OutcomesSanna Pikkusaari (15055802)Manuela Tumiati (15011915)Anni Virtanen (15055805)Jaana Oikkonen (14948281)Yilin Li (15055808)Fernando Perez-Villatoro (15055811)Taru Muranen (15055814)Matilda Salko (15055817)Kaisa Huhtinen (15055820)Anna Kanerva (15055823)Heidi Koskela (15055826)Johanna Tapper (15055829)Riitta Koivisto-Korander (15055832)Titta Joutsiniemi (15055835)Ulla-Maija Haltia (15055838)Heini Lassus (15055841)Sampsa Hautaniemi (14948308)Anniina Färkkilä (14948278)Johanna Hynninen (14932815)Sakari Hietanen (14932818)Olli Carpén (14932812)Liisa Kauppi (15055844)CancerMolecular and Cellular BiologyCancer Detection and DiagnosisTherapeutic Research and DevelopmentClinical Research and TrialsBiomarkersPrognostic biomarkersChemotherapyDNA Damage and RepairDrug ResistanceClinical drug resistanceGynecological CancersOvarian cancerPrecision Medicine<p>HRR gene mutations found in WGS/WES or clinical BRCA1/2 mutational testing.</p>2025-11-25T13:31:01ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30709570https://figshare.com/articles/dataset/Supplementary_Table_S1_from_Functional_Homologous_Recombination_Assay_on_FFPE_Specimens_of_Advanced_High-Grade_Serous_Ovarian_Cancer_Predicts_Clinical_Outcomes/30709570CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307095702025-11-25T13:31:01Z |
| spellingShingle | Supplementary Table S1 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes Sanna Pikkusaari (15055802) Cancer Molecular and Cellular Biology Cancer Detection and Diagnosis Therapeutic Research and Development Clinical Research and Trials Biomarkers Prognostic biomarkers Chemotherapy DNA Damage and Repair Drug Resistance Clinical drug resistance Gynecological Cancers Ovarian cancer Precision Medicine |
| status_str | publishedVersion |
| title | Supplementary Table S1 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes |
| title_full | Supplementary Table S1 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes |
| title_fullStr | Supplementary Table S1 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes |
| title_full_unstemmed | Supplementary Table S1 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes |
| title_short | Supplementary Table S1 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes |
| title_sort | Supplementary Table S1 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes |
| topic | Cancer Molecular and Cellular Biology Cancer Detection and Diagnosis Therapeutic Research and Development Clinical Research and Trials Biomarkers Prognostic biomarkers Chemotherapy DNA Damage and Repair Drug Resistance Clinical drug resistance Gynecological Cancers Ovarian cancer Precision Medicine |